Group One Trading’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Group One Trading’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,197	Closed	-$19.7K	–	8280
2023 Q4	$19.7K	Buy	+1,197	New	+$18.8K	﹤0.01%	5760
2023 Q3	–	Sell	-301	Closed	-$1.63K	–	8530
2023 Q2	$1.56K	Buy	301 +300	+30,000%	+$1.53K	﹤0.01%	7162
2023 Q1	$5	Buy	+1	New	+$5	﹤0.01%	7100
2022 Q1	–	Sell	-5,226	Closed	-$51.2K	–	8947
2021 Q4	$69K	Sell	5,226 -3,260	-38%	-$53.9K	﹤0.01%	6065
2021 Q3	$195K	Buy	8,486 +3,423	+68%	+$102K	﹤0.01%	5203
2021 Q2	$222K	Sell	5,063 -1,164	-19%	-$64.8K	﹤0.01%	5141
2021 Q1	$452K	Sell	6,227 -3,215	-34%	-$228K	﹤0.01%	4164
2020 Q4	$408K	Buy	9,442 +9,177	+3,463%	+$411K	﹤0.01%	3453
2020 Q3	$11K	Buy	+265	New	+$13.7K	﹤0.01%	5400

Group One Trading's ORTX Position: Q1 2024 in Review

Group One Trading sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 1,197 shares — an estimated $19.7K sold.

Group One Trading first reported a position in ORTX in Q3 2020 and held it in 9 quarters. The position peaked at $452K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Group One Trading reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 1,197 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $19.7K.
Group One Trading first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 9 quarters.
Group One Trading's Orchard Therapeutics plc American Depositary Shares position peaked at $452K in Q1 2021.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.